TrialInvestigational new drugs2011

Phase II study of irinotecan/S-1 combination chemotherapy for patients with oxaliplatin-refractory colorectal cancer.

Sung Yong Oh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.